ArticleJournal of the National Cancer Institute2015
BRCA2-branching out too?
Margaret R Spitz, Yanhong Liu, Christopher I Amos
Abstract readEditorialComment
In one paragraphArticle in Journal of the National Cancer Institute, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
3 authors.
Margaret R SpitzDan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX (MRS, YL); Dartmouth-Hitchcock Norris Cotton Cancer Center, Manchester, NH (CIA). spitz@bcm.edu.
Yanhong LiuDan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX (MRS, YL); Dartmouth-Hitchcock Norris Cotton Cancer Center, Manchester, NH (CIA).
Christopher I AmosDan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX (MRS, YL); Dartmouth-Hitchcock Norris Cotton Cancer Center, Manchester, NH (CIA).
Funding
Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3MGENETIC EPIDEMIOLOGY OF LUNG CANCERU01CA076293 · NCI · UNIVERSITY OF CINCINNATI · PI ANDERSON, MARSHALL W · 1999 to 2009
$11.5MTransdisciplinary Research in Cancer of the Lung (TRICL)U19CA148127 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I., LE MARCHAND, LOIC · 2010 to 2014
$10.9MInflammation Genes and Lung Cancer RiskR01CA127219 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SPITZ, MARGARET R · 2008 to 2013
$3.1MLung Cancer Prediction Models Incorporating Exome Data from Extreme PhenotypesK07CA181480 · NCI · BAYLOR COLLEGE OF MEDICINE · PI LIU, YANHONG · 2014 to 2017
$511kNCI NIH HHS K07 CA181480NCI NIH HHS K07CA181480NCI NIH HHS P30 CA023108NCI NIH HHS R01 CA127219NCI NIH HHS U01CA76293NCI NIH HHS U19CA148127
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Polymorphism, Single NucleotideBRCA2 ProteinCarcinoma, Squamous CellFemaleHead and Neck NeoplasmsHumansMaleBRCA2 Protein
What OpenQuestion holds
Textmetadata
Read underepoch 390